Author

F. Ricci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Ilsley· 2 shared A. Iwasaki· 2 shared A. S. Morgunov· 2 shared S. Fiedler· 2 shared S. R. A. Devenish· 2 shared T. P. J. Knowles· 2 shared V. Kosmoliaptsis· 2 shared A. A. A. Aguzzi· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

A. Ilsley

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

FGF10 triggers de novo alveologenesis in a BPD model: impact on the resident mesenchymal niche cells

S. Taghizadeh, C.-M. Chao, S. Guenther, L. Glaser, L. Gersmann, G. Michel, S. Kraut, K. Goth, J. Koepke, S. Herold, C. Samakovlis, N. Weissmann, g. Aquila, F. Ricci, L. Boyer, , S. Rivetti

This study shows that FGF10 administration rescues alveologenesis defects in a BPD mouse model by activating resident mesenchymal niche cells.

bioRxiv · Mar 14, 2022Cell Biology

Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration

S. Fiedler, S. R. A. Devenish, A. S. Morgunov, A. Ilsley, F. Ricci, M. Emmenegger, V. Kosmoliaptsis, E. S. Theel, J. R. Mills, A. M. Sholukh, A. A. A. Aguzzi, A. Iwasaki, A. K. Lynn, T. P. J. Knowles

The paper links antiviral activity of therapeutic antibodies to their affinity and concentration by comparing them to serological fingerprints in convalescent sera.

bioRxiv · Feb 3, 2022Biochemistry

Mutations in two SARS-CoV-2 variants of concern reflect two distinct strategies of antibody escape

S. Fiedler, V. Denninger, A. S. Morgunov, A. Ilsley, R. Worth, G. Meisl, C. K. Xu, M. A. Piziorska, F. Ricci, A. Y. Malik, S. R. A. Devenish, M. M. Schneider, V. Kosmoliaptsis, A. Aguzzi, A. Iwasaki, , T. P. J. Knowles

This study compares antibody escape mechanisms in SARS-CoV-2 alpha and beta variants, finding they use distinct strategies: alpha increases ACE2 binding affinity, while beta alters epitopes to reduce antibody access.

bioRxiv · Jul 23, 2021 · PreprintBiochemistry

Significant and conflicting correlation of IL-9 with Prevotella and Bacteroides in human colorectal cancer

E. Niccolai, E. Russo, S. Baldi, F. Ricci, G. Nannini, M. Pedone, F. C. Stingo, A. Taddei, M. N. Ringressi, P. Bechi, A. Mengoni, R. Fani, G. Bacci, C. fagorzi, C. Chiellini, , A. Amedei

The paper investigates the correlation between IL-9 and gut microbiota in colorectal cancer, finding conflicting associations with Prevotella and Bacteroides.

bioRxiv · Apr 28, 2020Immunology